APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pediatric Vaccines Market Outlook and Growth Opportunities 2026

27 December 2025204 pages

Choose your research edition.

Industry ResearchPediatric Vaccines Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Pediatric Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pediatric Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pediatric Vaccines market include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Vaccines Segment by Company

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

S K Chemicals

Serum Institute of India

Sinovac Biotech

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Takeda Pharmaceutical

Janssen

Pediatric Vaccines Segment by Type

Meningococcal Diseases

Influenza

Hepatitis

Pneumococcal Diseases

Diphtheria

Others

Pediatric Vaccines Segment by Application

Infant

Newborn

Dolescent

Child

Pediatric Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pediatric Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pediatric Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pediatric Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Pediatric Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediatric Vaccines industry.

Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pediatric Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pediatric Vaccines Industry Trends Table 2. Pediatric Vaccines Industry Drivers Table 3. Pediatric Vaccines Industry Opportunities and Challenges Table 4. Pediatric Vaccines Industry Restraints Table 5. Global Pediatric Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pediatric Vaccines Revenue Share by Company (2021-2026) Table 7. Global Pediatric Vaccines Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Pediatric Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Pediatric Vaccines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pediatric Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pediatric Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Pediatric Vaccines Company, Product Type & Application Table 13. Global Pediatric Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Meningococcal Diseases Table 18. Significant Companies of Influenza Table 19. Significant Companies of Hepatitis Table 20. Significant Companies of Pneumococcal Diseases Table 21. Significant Companies of Diphtheria Table 22. Significant Companies of Others Table 23. Global Pediatric Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Pediatric Vaccines Sales Volume by Type (2021-2026) & (W Units) Table 25. Global Pediatric Vaccines Sales Volume by Type (2027-2032) & (W Units) Table 26. Global Pediatric Vaccines Sales Volume Share by Type (2021-2026) Table 27. Global Pediatric Vaccines Sales Volume Share by Type (2027-2032) Table 28. Global Pediatric Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pediatric Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Pediatric Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Pediatric Vaccines Sales Value Share by Type (2021-2026) Table 32. Global Pediatric Vaccines Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Infant Table 34. Significant Companies of Newborn Table 35. Significant Companies of Dolescent Table 36. Significant Companies of Child Table 37. Global Pediatric Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Pediatric Vaccines Sales Volume by Application (2021-2026) & (W Units) Table 39. Global Pediatric Vaccines Sales Volume by Application (2027-2032) & (W Units) Table 40. Global Pediatric Vaccines Sales Volume Share by Application (2021-2026) Table 41. Global Pediatric Vaccines Sales Volume Share by Application (2027-2032) Table 42. Global Pediatric Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Pediatric Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Pediatric Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Pediatric Vaccines Sales Value Share by Application (2021-2026) Table 46. Global Pediatric Vaccines Sales Value Share by Application (2027-2032) Table 47. Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Pediatric Vaccines Sales by Region (2021-2026) & (W Units) Table 49. Global Pediatric Vaccines Sales Market Share by Region (2021-2026) Table 50. Global Pediatric Vaccines Sales by Region (2027-2032) & (W Units) Table 51. Global Pediatric Vaccines Sales Market Share by Region (2027-2032) Table 52. Global Pediatric Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Pediatric Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Pediatric Vaccines Sales Value Share by Region (2021-2026) Table 55. Global Pediatric Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Pediatric Vaccines Sales Value Share by Region (2027-2032) Table 57. Global Pediatric Vaccines Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Pediatric Vaccines Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Global Pediatric Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 62. Global Pediatric Vaccines Sales Market Share by Country (2021-2026) Table 63. Global Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 64. Global Pediatric Vaccines Sales Market Share by Country (2027-2032) Table 65. Global Pediatric Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Pediatric Vaccines Sales Value Market Share by Country (2021-2026) Table 67. Global Pediatric Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Pediatric Vaccines Sales Value Market Share by Country (2027-2032) Table 69. Bavarian Nordic Company Information Table 70. Bavarian Nordic Business Overview Table 71. Bavarian Nordic Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bavarian Nordic Pediatric Vaccines Product Portfolio Table 73. Bavarian Nordic Recent Development Table 74. Bharat Biotech Company Information Table 75. Bharat Biotech Business Overview Table 76. Bharat Biotech Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bharat Biotech Pediatric Vaccines Product Portfolio Table 78. Bharat Biotech Recent Development Table 79. Crucell Company Information Table 80. Crucell Business Overview Table 81. Crucell Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Crucell Pediatric Vaccines Product Portfolio Table 83. Crucell Recent Development Table 84. Dynavax Company Information Table 85. Dynavax Business Overview Table 86. Dynavax Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dynavax Pediatric Vaccines Product Portfolio Table 88. Dynavax Recent Development Table 89. LG Life Sciences Company Information Table 90. LG Life Sciences Business Overview Table 91. LG Life Sciences Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. LG Life Sciences Pediatric Vaccines Product Portfolio Table 93. LG Life Sciences Recent Development Table 94. Lupin Company Information Table 95. Lupin Business Overview Table 96. Lupin Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Lupin Pediatric Vaccines Product Portfolio Table 98. Lupin Recent Development Table 99. Mitsubishi Tanabe Pharma Company Information Table 100. Mitsubishi Tanabe Pharma Business Overview Table 101. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio Table 103. Mitsubishi Tanabe Pharma Recent Development Table 104. S K Chemicals Company Information Table 105. S K Chemicals Business Overview Table 106. S K Chemicals Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. S K Chemicals Pediatric Vaccines Product Portfolio Table 108. S K Chemicals Recent Development Table 109. Serum Institute of India Company Information Table 110. Serum Institute of India Business Overview Table 111. Serum Institute of India Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Serum Institute of India Pediatric Vaccines Product Portfolio Table 113. Serum Institute of India Recent Development Table 114. Sinovac Biotech Company Information Table 115. Sinovac Biotech Business Overview Table 116. Sinovac Biotech Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sinovac Biotech Pediatric Vaccines Product Portfolio Table 118. Sinovac Biotech Recent Development Table 119. AstraZeneca Company Information Table 120. AstraZeneca Business Overview Table 121. AstraZeneca Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. AstraZeneca Pediatric Vaccines Product Portfolio Table 123. AstraZeneca Recent Development Table 124. Baxter Company Information Table 125. Baxter Business Overview Table 126. Baxter Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Baxter Pediatric Vaccines Product Portfolio Table 128. Baxter Recent Development Table 129. GlaxoSmithKline Company Information Table 130. GlaxoSmithKline Business Overview Table 131. GlaxoSmithKline Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. GlaxoSmithKline Pediatric Vaccines Product Portfolio Table 133. GlaxoSmithKline Recent Development Table 134. Pfizer Company Information Table 135. Pfizer Business Overview Table 136. Pfizer Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Pfizer Pediatric Vaccines Product Portfolio Table 138. Pfizer Recent Development Table 139. Merck Company Information Table 140. Merck Business Overview Table 141. Merck Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Merck Pediatric Vaccines Product Portfolio Table 143. Merck Recent Development Table 144. Novartis Company Information Table 145. Novartis Business Overview Table 146. Novartis Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Novartis Pediatric Vaccines Product Portfolio Table 148. Novartis Recent Development Table 149. Sanofi Company Information Table 150. Sanofi Business Overview Table 151. Sanofi Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Sanofi Pediatric Vaccines Product Portfolio Table 153. Sanofi Recent Development Table 154. Shenzhen Kangtai Biological Products Company Information Table 155. Shenzhen Kangtai Biological Products Business Overview Table 156. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio Table 158. Shenzhen Kangtai Biological Products Recent Development Table 159. Takeda Pharmaceutical Company Information Table 160. Takeda Pharmaceutical Business Overview Table 161. Takeda Pharmaceutical Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Takeda Pharmaceutical Pediatric Vaccines Product Portfolio Table 163. Takeda Pharmaceutical Recent Development Table 164. Janssen Company Information Table 165. Janssen Business Overview Table 166. Janssen Pediatric Vaccines Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Janssen Pediatric Vaccines Product Portfolio Table 168. Janssen Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Pediatric Vaccines Distributors List Table 172. Pediatric Vaccines Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Pediatric Vaccines Product Image Figure 2. Global Pediatric Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pediatric Vaccines Sales (2021-2032) & (W Units) Figure 5. Global Pediatric Vaccines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pediatric Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Meningococcal Diseases Image Figure 10. Influenza Image Figure 11. Hepatitis Image Figure 12. Pneumococcal Diseases Image Figure 13. Diphtheria Image Figure 14. Others Image Figure 15. Global Pediatric Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Pediatric Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Pediatric Vaccines Sales Volume Share by Type (2021-2032) Figure 18. Global Pediatric Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pediatric Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Pediatric Vaccines Sales Value Share by Type (2021-2032) Figure 21. Infant Image Figure 22. Newborn Image Figure 23. Dolescent Image Figure 24. Child Image Figure 25. Global Pediatric Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Pediatric Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Pediatric Vaccines Sales Volume Share by Application (2021-2032) Figure 28. Global Pediatric Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pediatric Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Pediatric Vaccines Sales Value Share by Application (2021-2032) Figure 31. Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 32. Global Pediatric Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Pediatric Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Pediatric Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. North America Pediatric Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Pediatric Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Pediatric Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 42. South America Pediatric Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Pediatric Vaccines Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Pediatric Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Pediatric Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Pediatric Vaccines Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Pediatric Vaccines Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Diseases
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Diphtheria
  • Others
Applications
  • Infant
  • Newborn
  • Dolescent
  • Child
Companies covered
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Takeda Pharmaceutical
  • Janssen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Pediatric Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Pediatric Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pediatric Vaccines Market Dynamics
  1. 2.1 Pediatric Vaccines Industry Trends
  2. 2.2 Pediatric Vaccines Industry Drivers
  3. 2.3 Pediatric Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Vaccines Industry Restraints
3 Pediatric Vaccines Market by Company
  1. 3.1 Global Pediatric Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Pediatric Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Pediatric Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Pediatric Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Pediatric Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Pediatric Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Pediatric Vaccines Company Product Type and Application
  8. 3.8 Global Pediatric Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pediatric Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pediatric Vaccines Market by Type
  1. 4.1 Pediatric Vaccines Type Introduction
  2. 4.1.1 Meningococcal Diseases
  3. 4.1.2 Influenza
  4. 4.1.3 Hepatitis
  5. 4.1.4 Pneumococcal Diseases
  6. 4.1.5 Diphtheria
  7. 4.1.6 Others
  8. 4.2 Global Pediatric Vaccines Sales Volume by Type
  9. 4.2.1 Global Pediatric Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Pediatric Vaccines Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Pediatric Vaccines Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Pediatric Vaccines Sales Value by Type
  13. 4.3.1 Global Pediatric Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Pediatric Vaccines Sales Value by Type (2021-2032)
  15. 4.3.3 Global Pediatric Vaccines Sales Value Share by Type (2021-2032)
5 Pediatric Vaccines Market by Application
  1. 5.1 Pediatric Vaccines Application Introduction
  2. 5.1.1 Infant
  3. 5.1.2 Newborn
  4. 5.1.3 Dolescent
  5. 5.1.4 Child
  6. 5.2 Global Pediatric Vaccines Sales Volume by Application
  7. 5.2.1 Global Pediatric Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pediatric Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pediatric Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pediatric Vaccines Sales Value by Application
  11. 5.3.1 Global Pediatric Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pediatric Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pediatric Vaccines Sales Value Share by Application (2021-2032)
6 Pediatric Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Pediatric Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Pediatric Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pediatric Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pediatric Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pediatric Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Pediatric Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pediatric Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Pediatric Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pediatric Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Pediatric Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pediatric Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pediatric Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pediatric Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Pediatric Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pediatric Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pediatric Vaccines Sales Value Share by Country, 2025 VS 2032
7 Pediatric Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Pediatric Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pediatric Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pediatric Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Pediatric Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Pediatric Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Pediatric Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pediatric Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pediatric Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pediatric Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pediatric Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pediatric Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bavarian Nordic
  2. 8.1.1 Bavarian Nordic Company Information
  3. 8.1.2 Bavarian Nordic Business Overview
  4. 8.1.3 Bavarian Nordic Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
  6. 8.1.5 Bavarian Nordic Recent Developments
  7. 8.2 Bharat Biotech
  8. 8.2.1 Bharat Biotech Company Information
  9. 8.2.2 Bharat Biotech Business Overview
  10. 8.2.3 Bharat Biotech Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
  12. 8.2.5 Bharat Biotech Recent Developments
  13. 8.3 Crucell
  14. 8.3.1 Crucell Company Information
  15. 8.3.2 Crucell Business Overview
  16. 8.3.3 Crucell Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Crucell Pediatric Vaccines Product Portfolio
  18. 8.3.5 Crucell Recent Developments
  19. 8.4 Dynavax
  20. 8.4.1 Dynavax Company Information
  21. 8.4.2 Dynavax Business Overview
  22. 8.4.3 Dynavax Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Dynavax Pediatric Vaccines Product Portfolio
  24. 8.4.5 Dynavax Recent Developments
  25. 8.5 LG Life Sciences
  26. 8.5.1 LG Life Sciences Company Information
  27. 8.5.2 LG Life Sciences Business Overview
  28. 8.5.3 LG Life Sciences Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
  30. 8.5.5 LG Life Sciences Recent Developments
  31. 8.6 Lupin
  32. 8.6.1 Lupin Company Information
  33. 8.6.2 Lupin Business Overview
  34. 8.6.3 Lupin Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lupin Pediatric Vaccines Product Portfolio
  36. 8.6.5 Lupin Recent Developments
  37. 8.7 Mitsubishi Tanabe Pharma
  38. 8.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 8.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 8.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
  42. 8.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 8.8 S K Chemicals
  44. 8.8.1 S K Chemicals Company Information
  45. 8.8.2 S K Chemicals Business Overview
  46. 8.8.3 S K Chemicals Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
  48. 8.8.5 S K Chemicals Recent Developments
  49. 8.9 Serum Institute of India
  50. 8.9.1 Serum Institute of India Company Information
  51. 8.9.2 Serum Institute of India Business Overview
  52. 8.9.3 Serum Institute of India Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
  54. 8.9.5 Serum Institute of India Recent Developments
  55. 8.10 Sinovac Biotech
  56. 8.10.1 Sinovac Biotech Company Information
  57. 8.10.2 Sinovac Biotech Business Overview
  58. 8.10.3 Sinovac Biotech Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
  60. 8.10.5 Sinovac Biotech Recent Developments
  61. 8.11 AstraZeneca
  62. 8.11.1 AstraZeneca Company Information
  63. 8.11.2 AstraZeneca Business Overview
  64. 8.11.3 AstraZeneca Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
  66. 8.11.5 AstraZeneca Recent Developments
  67. 8.12 Baxter
  68. 8.12.1 Baxter Company Information
  69. 8.12.2 Baxter Business Overview
  70. 8.12.3 Baxter Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Pediatric Vaccines Product Portfolio
  72. 8.12.5 Baxter Recent Developments
  73. 8.13 GlaxoSmithKline
  74. 8.13.1 GlaxoSmithKline Company Information
  75. 8.13.2 GlaxoSmithKline Business Overview
  76. 8.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
  78. 8.13.5 GlaxoSmithKline Recent Developments
  79. 8.14 Pfizer
  80. 8.14.1 Pfizer Company Information
  81. 8.14.2 Pfizer Business Overview
  82. 8.14.3 Pfizer Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Pfizer Pediatric Vaccines Product Portfolio
  84. 8.14.5 Pfizer Recent Developments
  85. 8.15 Merck
  86. 8.15.1 Merck Company Information
  87. 8.15.2 Merck Business Overview
  88. 8.15.3 Merck Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Merck Pediatric Vaccines Product Portfolio
  90. 8.15.5 Merck Recent Developments
  91. 8.16 Novartis
  92. 8.16.1 Novartis Company Information
  93. 8.16.2 Novartis Business Overview
  94. 8.16.3 Novartis Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Novartis Pediatric Vaccines Product Portfolio
  96. 8.16.5 Novartis Recent Developments
  97. 8.17 Sanofi
  98. 8.17.1 Sanofi Company Information
  99. 8.17.2 Sanofi Business Overview
  100. 8.17.3 Sanofi Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Sanofi Pediatric Vaccines Product Portfolio
  102. 8.17.5 Sanofi Recent Developments
  103. 8.18 Shenzhen Kangtai Biological Products
  104. 8.18.1 Shenzhen Kangtai Biological Products Company Information
  105. 8.18.2 Shenzhen Kangtai Biological Products Business Overview
  106. 8.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
  108. 8.18.5 Shenzhen Kangtai Biological Products Recent Developments
  109. 8.19 Takeda Pharmaceutical
  110. 8.19.1 Takeda Pharmaceutical Company Information
  111. 8.19.2 Takeda Pharmaceutical Business Overview
  112. 8.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
  114. 8.19.5 Takeda Pharmaceutical Recent Developments
  115. 8.20 Janssen
  116. 8.20.1 Janssen Company Information
  117. 8.20.2 Janssen Business Overview
  118. 8.20.3 Janssen Pediatric Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Janssen Pediatric Vaccines Product Portfolio
  120. 8.20.5 Janssen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Vaccines Value Chain Analysis
  2. 9.1.1 Pediatric Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Vaccines Sales Mode & Process
  6. 9.2 Pediatric Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Vaccines Distributors
  9. 9.2.3 Pediatric Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst